Tags

Type your tag names separated by a space and hit enter

Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds.
BMJ. 2021 Jun 17; 373:n1570.BMJ

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34140312

Citation

Mahase, Elisabeth. "Covid-19: Regeneron's Antibody Combination Cuts Deaths in Seronegative Patients, Trial Finds." BMJ (Clinical Research Ed.), vol. 373, 2021, pp. n1570.
Mahase E. Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds. BMJ. 2021;373:n1570.
Mahase, E. (2021). Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds. BMJ (Clinical Research Ed.), 373, n1570. https://doi.org/10.1136/bmj.n1570
Mahase E. Covid-19: Regeneron's Antibody Combination Cuts Deaths in Seronegative Patients, Trial Finds. BMJ. 2021 Jun 17;373:n1570. PubMed PMID: 34140312.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds. A1 - Mahase,Elisabeth, Y1 - 2021/06/17/ PY - 2021/6/18/entrez PY - 2021/6/19/pubmed PY - 2021/6/19/medline SP - n1570 EP - n1570 JF - BMJ (Clinical research ed.) JO - BMJ VL - 373 SN - 1756-1833 UR - https://www.unboundmedicine.com/medline/citation/34140312/Covid_19:_Regeneron's_antibody_combination_cuts_deaths_in_seronegative_patients_trial_finds_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.